CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoSORIA, Francesco
Pubblicazioni
Risultati 1 - 20 di 87 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 41 | A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. | 2014 | Paola Milla; Chiara Fiorito; Francesco Soria; Silvia Arpicco; Luigi Cattel; Paolo Gontero |
| 42 | ABO blood group and rhesus factor are not associated with outcomes after radical cystectomy for non-metastatic urothelial carcinoma of the bladder | 2017 | D'andrea D.; Moschini M.; Soria F.; Gust K.M.; Briganti A.; Karakiewicz P.I.; Roupret M.; Shariat S.F. |
| 43 | Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool | 2018 | D'Andrea D.; Abufaraj M.; Susani M.; Ristl R.; Foerster B.; Kimura S.; Mari A.; Soria F.; Briganti A.; Karakiewicz P.I.; Gust K.M.; Roupret M.; Shariat S.F. |
| 44 | Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis. | 2011 | M. Oderda; E. Cattaneo; F. Soria; A. Barreca; L. Chiusa; B. Morelli; A. Zitella; P. Gontero |
| 45 | Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract | 2017 | Wirth G.J.; Haitel A.; Moschini M.; Soria F.; Klatte T.; Hassler M.R.; Bensalah K.; Briganti A.; Karam J.A.; Lotan Y.; Margulis V.; Raman J.D.; Remzi M.; Rioux-Leclercq N.; Robinson B.D.; Roupret M.; Wood C.G.; Shariat S.F. |
| 46 | Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization | 2020 | D'Andrea D.; Abufaraj M.; Soria F.; Gust K.; Haitel A.; Krakiewicz P.I.; Shariat S.F. |
| 47 | Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: State of affairs and new frontiers | 2018 | Soria F.; Shariat S.F. |
| 48 | Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer | 2017 | Soria F.; Lucca I.; Moschini M.; Mathieu R.; Roupret M.; Karakiewicz P.I.; Briganti A.; Rink M.; Gust K.M.; Hassler M.R.; Foerster B.; Abufarraj M.; Haitel A.; Klatte T.; Shariat S.F. |
| 49 | Characteristics and clinical significance of histological variants of bladder cancer | 2017 | Moschini M.; D'Andrea D.; Korn S.; Irmak Y.; Soria F.; Comperat E.; Shariat S.F. |
| 50 | Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients | 2017 | Soria, Francesco; Moschini, Marco; Wirth, Gregory J.; Gust, Kilian M.; Klatte, Tobias; Briganti, Alberto; Gontero, Paolo; Abufaraj, Mohammad; Özsoy, Mehmet; Karakiewicz, Pierre I.; Shariat, Shahrokh F. |
| 51 | Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy | 2018 | D'Andrea D.; Soria F.; Abufaraj M.; Gust K.; Foerster B.; Vartolomei M.D.; Kimura S.; Mari A.; Briganti A.; Remzi M.; Seitz C.K.; Mathieu R.; Karakiewicz P.I.; Shariat S.F. |
| 52 | Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study | 2018 | Soria, Francesco; Moschini, Marco; D'andrea, David; Abufaraj, Mohammad; Foerster, Beat; Mathiéu, Romain; Gust, Killian M.; Gontero, Paolo; Simone, Giuseppe; Meraney, Anoop; Krishna, Suprita; Konety, Badrinath; Rouprêt, Morgan; Perry, Matthew; Rowe, Edward; Ploussard, Guillaume; Boorjian, Stephen A.; Wiklund, Peter; Sooriakumaran, Prasanna; Shariat, Shahrokh F. |
| 53 | Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non–muscle-invasive Bladder Cancer | 2020 | D'Andrea D.; Soria F.; Abufaraj M.; Pones M.; Gontero P.; Machado A.T.; Waksman R.; Enikeev D.V.; Glybochko P.V.; Adonias S.P.; Nahas W.C.; Shariat S.F.; Chade D.C. |
| 54 | Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer | 2020 | D'Andrea D.; Soria F.; Zehetmayer S.; Stangl-Kremser J.; Grubmuller B.; Abufaraj M.; Gust K.; Kimura S.; Babjuk M.; Goldner G.M.; Shariat S.F. |
| 55 | Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer | 2019 | D'Andrea D.; Soria F.; Zehetmayer S.; Gust K.M.; Korn S.; Witjes J.A.; Shariat S.F. |
| 56 | Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: Any role in clinical practice? | 2018 | Soria F.; D'Andrea D.; Pohar K.; Shariat S.F.; Lotan Y. |
| 57 | Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration | 2019 | Zamboni S.; Soria F.; Mathieu R.; Xylinas E.; Abufaraj M.; D`Andrea D.; Tan W.S.; Kelly J.D.; Simone G.; Gallucci M.; Meraney A.; Krishna S.; Konety B.R.; Antonelli A.; Simeone C.; Baumeister P.; Mattei A.; Briganti A.; Gallina A.; Montorsi F.; Rink M.; Aziz A.; Karakiewicz P.I.; Roupret M.; Koupparis A.; Scherr D.S.; Ploussard G.; Sooriakumaran P.; Shariat S.F.; Moschini M. |
| 58 | DKK-1 in prostate cancer diagnosis and follow up | 2014 | Patrizia D'Amelio;Ilaria Roato;Marco Oderda;Francesco Soria;Andrea Zitella;Riccardo Ferracini;Giulio Mengozzi;Paolo Gontero;Giovanni Carlo Isaia |
| 59 | Drug strategies for bladder cancer in the elderly: is there promise for the future? | 2019 | Soria F.; Mosca A.; Gontero P. |
| 60 | The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer | 2016 | Soria F.; Moschini M.; Haitel A.; Wirth G.J.; Gust K.M.; Briganti A.; Roupret M.; Klatte T.; Hassler M.R.; Karakiewicz P.I.; Shariat S.F. |
Dettaglio
SORIA, Francesco
SCIENZE CHIRURGICHE
Copyright © 2020